Ebola preparedness requires years of research to develop, test, manufacture, and advance vaccines and treatments before an outbreak occurs. Investing in flexible technologies, broad-spectrum antivirals, and multivalent vaccines can help public health responders respond more quickly and effectively to future emerging infectious disease threats.
